![Thomas Brodin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Thomas Brodin formerly worked at Scandinavian Life Science Invest ApS, as Investment Director from 2012 to 2013.
Dr. Brodin received his doctorate degree in 1983 from the University of Lund and doctorate degree in 1988 from the University of Lund.
Anciens postes connus de Thomas Brodin
| Sociétés | Poste | Fin |
|---|---|---|
Scandinavian Life Science Invest ApS
 Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest's investment strategy aims to maximize return on investments. They are active investors in growth firms in the life science sector primarily in the areas of pharmaceutical development, biotechnology and medical technology. They generally take stakes from 10% to 49% in each firm, seeking to influence but not through a controlling interest. They invest in small and mid-sized life science firms primarily in Scandinavia and Europe. They seek long-term capital growth by constructing diversified portfolios through sector, firm size, development stage and financial status. They provide a combination of capital, industrial and financial expertise to their portfolio firms. Scandinavian Life Science Invest prefers to invest in phases after seed capital but before IPO. They look for firms with a strong patent position, clear market potential, proven medical need for the product or technology, expert science and scientific teams and incentives for key employees. The firm's exit strategies include trade sales, IPO and M&A. | Analyste en capital-investissement | 31/12/2013 |
Formation de Thomas Brodin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian Life Science Invest ApS
Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest's investment strategy aims to maximize return on investments. They are active investors in growth firms in the life science sector primarily in the areas of pharmaceutical development, biotechnology and medical technology. They generally take stakes from 10% to 49% in each firm, seeking to influence but not through a controlling interest. They invest in small and mid-sized life science firms primarily in Scandinavia and Europe. They seek long-term capital growth by constructing diversified portfolios through sector, firm size, development stage and financial status. They provide a combination of capital, industrial and financial expertise to their portfolio firms. Scandinavian Life Science Invest prefers to invest in phases after seed capital but before IPO. They look for firms with a strong patent position, clear market potential, proven medical need for the product or technology, expert science and scientific teams and incentives for key employees. The firm's exit strategies include trade sales, IPO and M&A. | Finance |
